Fortress Biotech, Inc. (FBIO)

Fortress Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	58.85	80.93	178.27	305.74	233.35	136.86
Cash & Short-Term Investments	58.85	80.93	178.27	305.74	233.35	136.86
Cash Growth	-18.61%	-54.60%	-41.69%	31.02%	70.51%	64.67%
Accounts Receivable	10.67	15.22	28.21	23.11	23.93	13.54
Other Receivables	0.17	0.17	0.14	0.68	0.74	0.87
Receivables	10.85	15.39	28.35	23.79	24.67	14.4
Inventory	11.79	10.21	14.16	9.86	1.4	0.86
Prepaid Expenses	2.58	10.5	9.66	7.07	6.72	4.13
Other Current Assets	2.21	-	-	-	-	-
Total Current Assets	86.28	117.02	230.43	346.46	266.15	156.25
Property, Plant & Equipment	17.56	23.5	33.01	34.07	32.41	33.91
Long-Term Investments	-	-	-	-	17.57	11.15
Other Intangible Assets	17.84	20.29	27.2	12.55	14.63	7.38
Other Long-Term Assets	5.41	6.72	3.66	3.42	2.66	17.73
Total Assets	127.09	167.53	294.3	396.5	333.41	226.42
Accounts Payable	34.03	34.81	57.24	47.43	11.41	10.05
Accrued Expenses	27.04	34.68	36.51	39.99	31.26	26.53
Short-Term Debt	-	3.93	5	0.81	-	-
Current Portion of Long-Term Debt	1.25	3	7.24	4.51	4.52	7.22
Current Portion of Leases	2.51	2.52	2.45	2.1	1.85	1.78
Current Income Taxes Payable	0.85	0.84	0.72	0.35	0.14	-
Current Unearned Revenue	-	-	-	2.61	-	-
Other Current Liabilities	4.62	5.13	18.55	3.24	2.58	0.03
Total Current Liabilities	70.31	84.91	127.72	101.04	51.76	45.62
Long-Term Debt	52.47	60.86	93.14	46.56	59.81	82.43
Long-Term Leases	15.29	18.28	21.57	20.99	22.89	23.71
Long-Term Deferred Tax Liabilities	-	0.23	-	-	-	-
Other Long-Term Liabilities	1.75	1.66	1.85	2.03	1.95	2.14
Total Liabilities	139.82	165.94	244.28	170.63	136.41	153.89
Common Stock	0.03	0.02	0.01	0.1	0.1	0.07
Additional Paid-In Capital	755.23	717.4	675.94	656.03	583	461.87
Retained Earnings	-734.1	-694.87	-634.23	-547.46	-482.76	-436.23
Comprehensive Income & Other	-	-	-	-	-	0.5
Total Common Equity	21.16	22.54	41.72	108.67	100.34	26.21
Minority Interest	-33.9	-20.96	8.3	117.2	96.66	46.32
Shareholders' Equity	-12.74	1.59	50.03	225.88	197	72.53
Total Liabilities & Equity	127.09	167.53	294.3	396.5	333.41	226.42
Total Debt	71.53	88.59	129.4	74.98	89.08	115.14
Net Cash (Debt)	-12.68	-7.67	48.87	230.77	144.28	21.72
Net Cash Growth	-	-	-78.82%	59.95%	564.37%	501.72%
Net Cash Per Share	-0.75	-0.95	8.25	42.37	30.06	5.95
Filing Date Shares Outstanding	27.6	19.23	8.65	6.97	6.33	5.23
Total Common Shares Outstanding	27.58	15.09	7.37	6.76	6.33	4.94
Working Capital	15.97	32.11	102.72	245.42	214.39	110.64
Book Value Per Share	0.77	1.49	5.66	16.07	15.86	5.31
Tangible Book Value	3.31	2.25	14.52	96.12	85.71	18.84
Tangible Book Value Per Share	0.12	0.15	1.97	14.21	13.55	3.82
Buildings	0.58	0.58	0.58	0.58	-	-
Machinery	1.61	1.61	10.76	8.68	7.61	6.4
Construction In Progress	-	0.03	0.95	2.03	0.5	1.16
Leasehold Improvements	13.18	13.18	13.18	13.18	10.58	9.36

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q